fda safety concerns bpc-157 immunogenicity Approval Status: Is It Approved for Human Use? FDA to Reconsider BPC-157 and
Description
For instance, a BAC of 0.08% means there are 0.08 grams of alcohol per 100 milliliters of blood
That distinction matters for patient safety, liability, and informed consent

BPC-157 is an experimental peptide with emerging research suggesting potential benefits for tissue repair, inflammation control, and gut support

(10 g or 10 ng/kg/day), topical (1.0 g in cream), or per-oral (0.16 g/mL in drinking water) over 90 days and described directional improvements across biomechanical, functional, macroscopic, and histological endpoints, though specific effect sizes and p-values are not reported in the abstract

A 2023 study demonstrated that ionic liquid microemulsion formulations improved GHK-Cu topical delivery by 3-fold compared to conventional vehicles (PMC10643103)
